Genprex receives Canadian Patent Allowance for Reqorsa gene therapy combination in lung cancer
Transgene expands myvac platform into non-small cell lung cancer with TG4070
Arletta Pharma Solutions names new chief medical officer
Oncoinvent reports recruitment milestone in Phase 2 study of Radspherin in ovarian cancer
FDA accepts Genentech application for Lunsumio and Polivy combination in large B-cell lymphoma
Getinge launches Fluobeam LS for fluorescence‑guided small‑incision surgery
Organon and Samsung Bioepis expand Canada biosimilar partnership with PYZCHIVA
IDEAYA Biosciences names Yujiro S. Hata as new chairman
Niowave and Ratio Therapeutics agree Actinium-225 supply deal for targeted alpha therapies
Minghui Pharmaceutical presents MHB018A Phase I/II results for thyroid eye disease at ENDO 2026